Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Last Close
32.65
Sep 11 • 3:59 PM ET Dollar change+1.47 Percentage change(4.71%)
Aftermarket Close
32.93
Aftermarket • 7:59 PM ET Dollar change+0.28 Percentage change(0.86%)
Category
US Equities - Industry Sector
Sponsor
Elevate Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
1.00%
Inverse/Leveraged
IPO
Oct 24, 2023
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
4.24%
SMA50
45.50%
SMA200
74.60%
Return% 1Y
343.23%
Return% 3Y
-
Return% 5Y
-
Return% 10Y
Return% SI
Flows% 1M
-45.47%
Flows% 3M
-36.49%
Flows% YTD
-31.76%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
14
AUM
141.53M
NAV/sh
52W High
42.39 -22.98%
52W Low
13.60 140.07%
Volatility
5.72% 9.00%
ATR (14)
2.62
RSI (14)
58.94
Beta
0.18
Rel Volume
0.86
Avg Volume
290.38K
Volume
250,627
Perf Week
-3.69%
Perf Month
104.70%
Perf Quarter
112.29%
Perf Half Y
67.26%
Perf YTD
122.11%
Perf Year
85.51%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
31.18
Price
32.65
Change %
4.71%
YieldMax MRNA Option Income Strategy ETF seeks current income; exposure to the share price of the common stock of Moderna, Inc. ("MRNA"), subject to a limit on potential investment gains is the secondary consideration. The fund advisor will seek to employ the fund's investment strategy as the fund relates to MRNA regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. The fund is non-diversified.